Organisation paid for research Program year 2024 Source: CMS Open Payments

Veritas Research Corp.

Neither a doctor nor a teaching hospital

Research payments

$105,031

39 payments

Through program year 2024, Veritas Research Corp. is reported as receiving $105,031 in research payments, across 39 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$45	1
2023	Research	$62	1
2021	Research	$2,458	3
2020	Research	$52,987	18
2019	Research	$49,478	16

Breakdown

Who paid Research payments · program years 2019–2024

Bayer HealthCare Pharmaceuticals Inc. $104,181 35 payments
Merck Sharp & Dohme Corporation $850 4 payments

Studies the money was for Research payments · program years 2019–2024

BAY 94-8862 ph 3 conventional in diab nephropathy $61,482 21 payments
BAY94-8862 ph 3 conventional in diabetic nephropathy $42,699 14 payments
A Phase III Multicenter, Double-Blind, Randomized Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A XR a Fixed-Dose Combination Tablet of Sitagliptin and Extended-Release Metformin in Pediatric Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Therapy Alone or in Combination with Insulin $850 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.